Have novel endpoints added any value in Phase 1 clinical trials in Oncology?

Date 02 July 2014
Event 8th European Scientific Oncology Conference
Session Controversies in methods for early clinical anticancer research
Topics Drug Development
Translational Research
Presenter A. Tolcher